J Eric Ahlskog. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AnimalsApoptosis/drug effectsApoptosis/physiologyApoptosis Regulatory Proteins/antagonists & inhibitorsApoptosis Regulatory Proteins/metabolismCarbazoles/pharmacologyCarbazoles/therapeutic useClinical Trials as Topic/statistics & numerical dataCytoprotection/drug effectsCytoprotection/physiologyDisease Models, AnimalDrug Evaluation, Preclinical/methodsDrug Evaluation, Preclinical/standardsEnzyme Inhibitors/pharmacologyEnzyme Inhibitors/therapeutic useHumansIndoles/pharmacologyIndoles/therapeutic useJNK Mitogen-Activated Protein Kinases/antagonists & inhibitorsJNK Mitogen-Activated Protein Kinases/metabolismNeuroprotective Agents/pharmacologyNeuroprotective Agents/therapeutic useParkinson Disease/drug therapyParkinson Disease/physiopathologyTreatment Failure
Substances： See more » Apoptosis Regulatory ProteinsCarbazolesEnzyme InhibitorsIndolesNeuroprotective Agents3,9-bis((ethylthio)methyl)-K-252aJNK Mitogen-Activated Protein Kinases
Year: 2007 PMID： 17923609 DOI： 10.1212/01.wnl.0000277645.60799.0e
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910